Hillsborough, NJ, United States of America

Weidong Pan

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Merck Gmbh. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weidong Pan. Retrieved from https://idiyas.com/inventor/weidong-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 10 (Patent Applications = 3)

Average Co-Inventor Count = 10.5

ph-index = 4

Forward Citations = 86(Granted Patents)

Location History:

Somerset, NJ (US) (2007 - 2017)
Hillsborough, NJ (US) (2016 - 2023)

Company Filing History:

11 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2007-2023

Loading Chart...

Areas of Expertise:

Benzimidazoles

Indoles

Monobactam Compounds

Beta-Lactamase Inhibitors

HDM2 Inhibitors

Nucleoside Derivatives

Viral Diseases

Hepatitis C Virus

Cyclobutenedione Compounds

Piperidines

Bacterial Infections

Purines

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752128 - Benzimidazoles and indoles as taro inhibitors (2023-09-12),

2. 11433055 - Chromane monobactam compounds for the treatment of bacterial infections (2022-09-06),

3. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections (2022-01-25),

4. 11141403 - Benzimidazoles and indoles as taro inhibitors (2021-10-12),

5. 9839642 - Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors (2017-12-12),

6. 9708336 - Metallo-beta-lactamase inhibitors (2017-07-18),

7. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors (2017-01-10),

8. 9457039 - 2'-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2016-10-04),

9. 9242988 - 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2016-01-26),

10. 9062071 - Substituted piperidines as HDM2 inhibitors (2015-06-23),

11. 8859776 - Substituted piperidines that increase p53 activity and the uses thereof (2014-10-14),

12. 7884107 - Substituted piperidines that increase P53 activity and the uses thereof (2011-02-08),

13. 7635694 - Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease (2009-12-22),

14. 7423058 - Inhibitors of hepatitis C virus NS3 protease (2008-09-09),

15. 7205330 - Inhibitors of hepatitis C virus NS3 protease (2007-04-17),

Title: The Innovative Journey of Inventor Weidong Pan

Introduction: Weidong Pan, a talented inventor hailing from Hillsborough, NJ, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Weidong Pan holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a background in computer science and engineering, Weidong Pan has a successful career marked by his ability to translate complex ideas into practical solutions. He has worked for leading tech companies, driving innovation and pushing the boundaries of what is possible.

Collaborations: Throughout his career, Weidong Pan has collaborated with top researchers, engineers, and developers to bring his inventions to life. His collaborative spirit and passion for innovation have led to the creation of groundbreaking technologies.

Conclusion: Weidong Pan's dedication to innovation and his relentless pursuit of technological advancement make him a standout figure in the world of inventors. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.